How we diagnose and treat iron deficiency anemia
暂无分享,去创建一个
[1] P. Kalra,et al. A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] L. Thomsen,et al. Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial) , 2015, Vox sanguinis.
[3] J. Powell,et al. Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis , 2015, PloS one.
[4] A. Bircher,et al. Hypersensitivity from intravenous iron products. , 2014, Immunology and allergy clinics of North America.
[5] B. Favrat,et al. Evaluation of a Single Dose of Ferric Carboxymaltose in Fatigued, Iron-Deficient Women – PREFER a Randomized, Placebo-Controlled Study , 2014, PloS one.
[6] I. Macdougall,et al. A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD. , 2014, Clinical journal of the American Society of Nephrology : CJASN.
[7] Y. Akın,et al. Impact of iron supplementation on sexual dysfunction of women with iron deficiency anemia in short term: a preliminary study. , 2014, The journal of sexual medicine.
[8] L. F. Allen,et al. A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy , 2014, American journal of hematology.
[9] Seth R Flaxman,et al. A systematic analysis of global anemia burden from 1990 to 2010. , 2014, Blood.
[10] W. Strauss,et al. Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min , 2013, American journal of hematology.
[11] W. Reinisch,et al. A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED) , 2013, The American Journal of Gastroenterology.
[12] W. Ondo,et al. Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome. , 2013, Mayo Clinic proceedings.
[13] J. McClung,et al. Iron nutrition and premenopausal women: effects of poor iron status on physical and neuropsychological performance. , 2013, Annual review of nutrition.
[14] Alan R. Ellis,et al. The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. , 2013, The American journal of medicine.
[15] B. Biggs,et al. Control of iron deficiency anemia in low- and middle-income countries. , 2013, Blood.
[16] N. Hevelone,et al. Comparative rates of adverse events with different formulations of intravenous iron , 2012, American journal of hematology.
[17] O. Irion,et al. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose , 2012, Journal of perinatal medicine.
[18] Alissa Westerlund,et al. Iron deficiency in infancy is associated with altered neural correlates of recognition memory at 10 years. , 2012, The Journal of pediatrics.
[19] B. Myers,et al. Comparative efficacy and safety of intravenous ferric carboxymaltose (Ferinject) and iron(III) hydroxide dextran (Cosmofer) in pregnancy , 2012, Obstetric medicine.
[20] N. Dahl,et al. Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia , 2011, American journal of hematology.
[21] U. Kolb,et al. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[22] M. Auerbach,et al. Clinical use of intravenous iron: administration, efficacy, and safety. , 2010, Hematology. American Society of Hematology. Education Program.
[23] Catherine M. Dormitzer,et al. Use of parenteral iron products and serious anaphylactic‐type reactions , 2010, American journal of hematology.
[24] D. Coyne,et al. Intravenous iron: From anathema to standard of care , 2008, American journal of hematology.
[25] J. Glaspy,et al. Clinical update: intravenous iron for anaemia , 2007, The Lancet.
[26] J. Critchley,et al. Adverse events associated with intravenous iron infusion (low-molecular-weight iron dextran and iron sucrose): a systematic review , 2007 .
[27] S. Bhandari,et al. Tolerability and efficacy of parenteral iron therapy in hemodialysis patients, a comparison of preparations , 2007 .
[28] M. Sipahioğlu,et al. Is There a Difference between the Allergic Potencies of the Iron Sucrose and Low Molecular Weight Iron Dextran? , 2007, Renal failure.
[29] C. Gasche,et al. Systematic review: managing anaemia in Crohn's disease , 2006, Alimentary pharmacology & therapeutics.
[30] W. Bergfeld,et al. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. , 2006, Journal of the American Academy of Dermatology.
[31] G. Chertow,et al. Update on adverse drug events associated with parenteral iron. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[32] V. Eclache,et al. Pica and food craving in patients with iron-deficiency anemia: a case-control study in France. , 2005, The American journal of medicine.
[33] B. Danielson. Structure, chemistry, and pharmacokinetics of intravenous iron agents. , 2004, Journal of the American Society of Nephrology : JASN.
[34] R. Stoltzfus. Iron Deficiency: Global Prevalence and Consequences , 2003, Food and nutrition bulletin.
[35] C. Crowther,et al. Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial. , 2003, The American journal of clinical nutrition.
[36] J. Cook,et al. The quantitative assessment of body iron. , 2003, Blood.
[37] A. Nissenson,et al. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. , 2002, Kidney international.
[38] I. Macdougall,et al. Intravenous iron sucrose: establishing a safe dose. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[39] J. Haas,et al. Iron-Deficiency Anemia: Reexamining the Nature and Magnitude of the Public Health Problem Iron Deficiency and Reduced Work Capacity: A Critical Review of the Research to Determine a Causal Relationship 1,2 , 2001 .
[40] E. Barton,et al. Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation. , 2000, The American journal of medicine.
[41] E. Simpson,et al. Pica during pregnancy in low-income women born in Mexico. , 2000, The Western journal of medicine.
[42] J. Beard. Effectiveness and strategies of iron supplementation during pregnancy. , 2000, The American journal of clinical nutrition.
[43] D. Brewster,et al. An iron treatment trial in an Aboriginal community: Improving non‐adherence , 1999, Journal of paediatrics and child health.
[44] M. Auerbach,et al. Value of methylprednisolone in prevention of the arthralgia-myalgia syndrome associated with the total dose infusion of iron dextran: a double blind randomized trial. , 1998, The Journal of laboratory and clinical medicine.
[45] W. Reinisch,et al. Intravenous Iron and Erythropoietin for Anemia Associated with Crohn Disease , 1997, Annals of Internal Medicine.
[46] K. Punnonen,et al. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. , 1997, Blood.
[47] S. Fishbane,et al. The safety of intravenous iron dextran in hemodialysis patients. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[48] R. Lerner,et al. Clinical use of the total dose intravenous infusion of iron dextran. , 1988, The Journal of laboratory and clinical medicine.
[49] W. Crosby. Whatever became of chlorosis? , 1987, JAMA.
[50] J. Adamson,et al. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. , 1987, The New England journal of medicine.
[51] R. Hamstra,et al. Intravenous iron dextran in clinical medicine. , 1980, JAMA.
[52] P. Kopelman. Raised mean cell volume and meningoencephalitis associated with Mycoplasma pneumoniae infection. , 1977, British medical journal.
[53] V. S. Nadig,et al. Comparative therapeutic study of T.D.I. and I.M. injections of iron dextran complex in anaemia. , 1973, The Journal of the Association of Physicians of India.
[54] K. Varde. TREATMENT OF 300 CASES OF IRON DEFICIENCY OF PREGNANCY BY TOTAL DOSE INFUSION OF IRON-DEXTRAN COMPLEX. , 1965, The Journal of obstetrics and gynaecology of the British Commonwealth.
[55] R. Wallerstein,et al. THE TREATMENT OF IRON-DEFICIENCY ANEMIA WITH INTRAVENOUS IRON DEXTRAN. , 1964, Blood.
[56] I. Baird,et al. Intramuscular iron therapy in iron-deficiency anaemia. , 1954, Lancet.
[57] J. Howell,et al. Syndrome of anemia, dysphagia and glossitis (Plummer Vinson syndrome). , 1953, The New England journal of medicine.
[58] J. Nissim. Intravenous administration of iron. , 1947, Lancet.
[59] C. Moore,et al. Observations on the effect of massive doses of iron given intravenously to patients with hypochromic anemia. , 1946, Proceedings [of the] annual meeting. Central Society for Clinical Research.
[60] R. Stockman. The Treatment of Chlorosis by Iron and some Other Drugs , 1893, British medical journal.
[61] L. Leibovici,et al. The safety of intravenous iron preparations: systematic review and meta-analysis. , 2015, Mayo Clinic proceedings.
[62] J. Winchester,et al. A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patients. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[63] T. Bothwell,et al. Iron absorption. I. Factors influencing absorption. , 1958, The Journal of laboratory and clinical medicine.